Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

DDW presentations support efficacy of exisulind in FAP and related conditions

May 24, 2000

Inhibitors of cyclin-dependent kinases claimed by DuPont for cancer

May 24, 2000

Proteasome inhibitors and their use presented by Max Planck

May 24, 2000

Marine sponges yield new biologically active discorhabdin compounds

May 24, 2000

Epimmune and Pharmacia report data on promising cancer vaccine

May 24, 2000

NCI signs CRADA with Exelixis

May 24, 2000

New PYY analogue with picomolar affinity for Y4 receptors presented at DDW

May 23, 2000

SuperGen acquires rights to lucanthone for treatment of brain tumors

May 23, 2000

Cyclopentenone-based antitumor agents synthesized in China

May 23, 2000

Frequency of adverse events due to photodynamic therapy called into question

May 23, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...